tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
US Market
ELTX
Elicio Therapeutics
RESEARCH TOOLSreports

Elicio Therapeutics (ELTX) Financial Statements

Compare
223 Followers

Elicio Therapeutics Financial Overview

Elicio Therapeutics's market cap is currently $192.06M. The company's EPS TTM is $-0.45; its P/E ratio is -3.95; Elicio Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 28.31M
Gross Profit$ -1.13M$ -1.18M$ -1.17M$ -1.06M$ 27.08M
Operating Income$ -37.71M$ -44.99M$ -35.74M$ -23.73M$ -39.31M
EBITDA$ -36.59M$ -50.27M$ -32.97M$ -23.55M$ -51.92M
Net Income$ -39.57M$ -51.90M$ -35.20M$ -28.21M$ -26.40M
Balance Sheet
Cash & Short-Term Investments$ 18.56M$ 17.62M$ 12.89M$ 7.80M$ 88.76M
Total Assets$ 25.86M$ 28.18M$ 27.15M$ 22.66M$ 96.51M
Total Debt$ 14.51M$ 26.04M$ 6.92M$ 7.48M$ 4.66M
Net Debt$ -4.05M$ 8.42M$ -5.98M$ -316.00K$ -84.09M
Total Liabilities$ 24.23M$ 39.49M$ 15.77M$ 13.75M$ 15.01M
Stockholders' Equity$ 1.64M$ -11.31M$ 11.37M$ 8.91M$ 81.51M
Cash Flow
Free Cash Flow$ -36.97M$ -37.16M$ -32.76M$ -22.83M$ -24.46M
Operating Cash Flow$ -36.95M$ -37.07M$ -32.69M$ -22.18M$ -23.94M
Investing Cash Flow$ -16.00K$ -84.00K$ -32.00K$ -654.00K$ -525.36K
Financing Cash Flow$ 36.70M$ 42.32M$ 38.61M$ 21.20M$ 19.39M
Currency in USD

Elicio Therapeutics Earnings and Revenue History

Income Statement >

Elicio Therapeutics Debt to Assets

Balance Sheet >

Elicio Therapeutics Cash Flow

Cash Flow >

Elicio Therapeutics Forecast EPS vs Actual EPS

Earnings >